Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
08 December 2015 - 8:05AM
Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today
announced that its Board of Directors has declared a quarterly cash
dividend payment on the Company's 10.50% Series E Convertible
Preferred Stock (the "Series E Preferred Stock").
The quarterly dividend on the Series E Preferred
Stock is payable on January 4, 2016 to holders of record at the
close of business on December 18, 2015.
The quarterly dividend payment on the Series E
Preferred Stock will be $0.65625 per share, which is equivalent to
an annualized 10.50% per share, based on the $25.00 per share
stated liquidation preference, accruing from October 1, 2015
through December 31, 2015. The Series E Preferred Stock is listed
on the NASDAQ Capital Market and trades under the ticker symbol
"PPHMP".
About Peregrine Pharmaceuticals, Inc.Peregrine
Pharmaceuticals, Inc. is a biopharmaceutical company with a
pipeline of novel drug candidates in clinical trials focused on the
treatment of cancer. The company's lead immunotherapy candidate,
bavituximab, is in Phase III development for the treatment of
previously treated non-small cell lung cancer (the "SUNRISE trial")
along with several investigator-sponsored trials evaluating other
treatment combinations and additional oncology indications.
Peregrine also has in-house cGMP manufacturing capabilities
through its wholly-owned subsidiary Avid Bioservices, Inc.
(www.avidbio.com), which provides development and biomanufacturing
services for both Peregrine and third-party customers. For more
information, please visit www.peregrineinc.com.
Contacts:
Jay Carlson
Peregrine Pharmaceuticals, Inc.
(800) 987-8256
info@peregrineinc.com
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From Apr 2024 to May 2024
Avid Bioservices (NASDAQ:CDMO)
Historical Stock Chart
From May 2023 to May 2024